| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |